Safety study of SSS39 injection in healthy Chinese adults
This trial tests a new injection called SSS39 in healthy people to see if it's safe and how the body processes it. You must be between 18 and 45, in good health, and not have certain medical conditions or use specific medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- You are in generally good health with no serious medical conditions.
- Your body mass index (BMI) is between 19 and 28.
- Men weigh at least 50 kg (110 lbs), women at least 45 kg (99 lbs).
- You have not taken any prescription or over-the-counter drugs, supplements, or certain foods (like grapefruit) in the past 2 weeks.
- You have no history of allergies to sirolimus, polyethylene glycol, or lactose, and no history of organ transplant or immune system disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.
This study tests a new drug called SSS67 given as a single injection into a vein. It aims to see how safe it is in healthy adults and how the body processes it.
This trial tests a new medication called SV003 in healthy people to see if it's safe and how the body processes it. You may be able to join if you are in good health and meet certain weight and lifestyle requirements.
This study tests a medication called sirolimus to see if it can help older adults stay healthy and independent. The trial is looking for people aged 65 and older who live at home and do not have serious memory problems or major health conditions like kidney or liver disease.
This trial tests a new medicine called SK-09 in healthy volunteers to see if it is safe and how the body processes it. The results will help decide the right dose for future studies.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
Hear when a new Safety and Tolerability in Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.